
The FDA has approved a quadrivalent formula of the adjuvanted seasonal influenza vaccine from Seqiris.

The FDA has approved a quadrivalent formula of the adjuvanted seasonal influenza vaccine from Seqiris.

With approval, the GLP-1 receptor agonist becomes the first diabetes drug approved for reducing MACE in patients with and without established cardiovascular.

A military service member talks about some of the ways the Navy is implementing new programs to improve mental health conditions.

Early psychosis patients experienced better social functioning after cognitive behavior therapy.

As symptoms reportedly reach the majority of the US physician population, it's time to discuss individual strategy to reduce the risk and effect of burnout.

Patients express worry related to using opioids and that they are not always on the same page as their provider.

How can primary care and family physicians help put concerned patients at ease?

The Novalung System is the first ECMO device approved for use for more than 6 hours.

Clinical trial data for the lipid-lowering non-statin agent indicates it can lower LDL-C by as much as 18% when combined with maximally tolerated statins.

A secondary analysis of patients with prior stroke, TIA, or thromboembolism from AUGUSTUS is revealing more about the use of apixaban in patients with AFib.

The adoption of remote treatment monitoring apps improves the timely identification of complications and intervention by care teams.

New data indicates a combination of 3 natural extracts added to standard therapy could provide benefits in patients with uncontrolled hypertension.

Varenicline should be considered as a treatment option for smoking cessation, the findings suggest.

New drug more often linked to a full ON response from Parkinson disease patients at 30 minutes when compared to a placebo.

The approval came following 2 Complete Response Letters from the FDA.

An analysis of the French cohort from the TST trial was presented during ISC 2020 in Los Angeles, CA.

The new low nicotine products contain 95% less nicotine than the top 100 cigarette brands in the US, according to 22nd Century Group.

Research from the Karolinska Institute indicates ESC/EAS 2019 dyslipidemia guidelines could create an unforeseen financial burden due to new eligibility for PSCK9 class.

Younger patients display increased susceptibility to H1N1 relative to H3N2, according to study findings.

Despite a lack of previous research, investigators conclude in a new study that sex has a moderate effect on symptom presentation following a traumatic brain injury.

Macrolide use during the first trimester was linked to an increase in major malformations—specifically cardiovascular malformations—in children.

A fourth-year medical student keeps a log of the sessions he attends and his perspective on information from the SCCM's 49th Annual Critical Care Congress.

A new analysis is revealing more about how using a patient portal can aid in medication adherence and HbA1c management among diabetics.

The Prometra II offers a pressure-driven, valve-gated delivery mechanism that allows for novel programming modes of intermittent flow followed by periods of no flow—a feature unique to this device.

New data on the use of polygenic risk scores for predicting certain forms of cardiovascular disease raise questions about the validity of genetic scores in real-world settings.

The associations between chemicals and autism were significantly stronger in males than females.

Current patients can easily exceed the current CDC guidelines for opioids, recent study findings suggest.

Azathioprine is linked to a slightly higher eGFR for patients with inflammatory bowel disease.

A fourth-year medical student offers perspective on a study examining machine learning models being presented at CCC 49 in Orlando, FL as part of HCPLive's Notes from Rounds program.

A fourth-year medical student offers perspective on a study examining the use of ketamine in ICUs being presented at CCC 49 in Orlando, FL as part of HCPLive's Notes from Rounds program.